[HTML][HTML] Cost-effectiveness of human papillomavirus vaccination in Germany
O Damm, J Horn, RT Mikolajczyk… - Cost Effectiveness and …, 2017 - Springer
Background The aim of this study was to assess the cost-effectiveness of human
papillomavirus (HPV) vaccination in addition to the current cervical cancer screening …
papillomavirus (HPV) vaccination in addition to the current cervical cancer screening …
Cost-effectiveness of human papillomavirus vaccination in Germany
O Damm, J Horn, RT Mikolajczyk… - Cost Effectiveness and …, 2017 - infona.pl
Background The aim of this study was to assess the cost-effectiveness of human
papillomavirus (HPV) vaccination in addition to the current cervical cancer screening …
papillomavirus (HPV) vaccination in addition to the current cervical cancer screening …
Cost-effectiveness of human papillomavirus vaccination in Germany
O Damm, J Horn, RT Mikolajczyk… - … allocation: C/E, 2017 - pubmed.ncbi.nlm.nih.gov
Background The aim of this study was to assess the cost-effectiveness of human
papillomavirus (HPV) vaccination in addition to the current cervical cancer screening …
papillomavirus (HPV) vaccination in addition to the current cervical cancer screening …
Cost-effectiveness of human papillomavirus vaccination in Germany
O Damm, J Horn, RT Mikolajczyk… - Cost Effectiveness …, 2017 - search.proquest.com
Background The aim of this study was to assess the cost-effectiveness of human
papillomavirus (HPV) vaccination in addition to the current cervical cancer screening …
papillomavirus (HPV) vaccination in addition to the current cervical cancer screening …
Cost-effectiveness of human papillomavirus vaccination in Germany
O Damm, J Horn, RT Mikolajczyk, MEE Kretzschmar… - 2017 - edoc.rki.de
Background: The aim of this study was to assess the cost-effectiveness of human
papillomavirus (HPV) vaccination in addition to the current cervical cancer screening …
papillomavirus (HPV) vaccination in addition to the current cervical cancer screening …
[HTML][HTML] Cost-effectiveness of human papillomavirus vaccination in Germany
O Damm, J Horn, RT Mikolajczyk… - … Allocation: C/E, 2017 - ncbi.nlm.nih.gov
Background The aim of this study was to assess the cost-effectiveness of human
papillomavirus (HPV) vaccination in addition to the current cervical cancer screening …
papillomavirus (HPV) vaccination in addition to the current cervical cancer screening …
Cost-effectiveness of human papillomavirus vaccination in Germany.
O Damm, J Horn, RT Mikolajczyk… - Cost Effectiveness …, 2017 - search.ebscohost.com
Background: The aim of this study was to assess the cost-effectiveness of human
papillomavirus (HPV) vaccination in addition to the current cervical cancer screening …
papillomavirus (HPV) vaccination in addition to the current cervical cancer screening …
[PDF][PDF] Cost-effectiveness of human papillomavirus vaccination in Germany
O Damm, J Horn, RT Mikolajczyk… - 2017 - researchinformation.umcutrecht.nl
Background: The aim of this study was to assess the cost-effectiveness of human
papillomavirus (HPV) vaccination in addition to the current cervical cancer screening …
papillomavirus (HPV) vaccination in addition to the current cervical cancer screening …
Cost-effectiveness of human papillomavirus vaccination in Germany.
O Damm, J Horn, RT Mikolajczyk, MEE Kretzschmar… - 2017 - hzi.openrepository.com
Cost-effectiveness of human papillomavirus vaccination in Germany Page 1 Damm et al. Cost
Eff Resour Alloc (2017) 15:18 DOI 10.1186/s12962-017-0080-9 RESEARCH Cost-effectiveness …
Eff Resour Alloc (2017) 15:18 DOI 10.1186/s12962-017-0080-9 RESEARCH Cost-effectiveness …
[PDF][PDF] Cost-effectiveness of human papillomavirus vaccination in Germany
O Damm, J Horn, RT Mikolajczyk, MEE Kretzschmar… - 2017 - core.ac.uk
Background: The aim of this study was to assess the cost-effectiveness of human
papillomavirus (HPV) vaccination in addition to the current cervical cancer screening …
papillomavirus (HPV) vaccination in addition to the current cervical cancer screening …